PURE Bioscience Inc (PURE) NPV
$0.0037
(5.86%)
- Add to watchlist
- This stock can be held in a
$0.0037
(5.86%)
Deal for just £11.95 per trade in a
Fund and Share Account
$0.0037
(5.86%)
Business summary
PURE Bioscience, Inc. is a creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial. The Company is focused on developing and commercializing its proprietary antimicrobial products, primarily in the food and beverage industry. It provides solutions to combat the health and environmental challenges of pathogens and hygienic control. Its technology platform is based on patented, stabilized ionic silver, and its initial products contain SDC. Its registered offerings include PURE Hard Surface, a food contact surface sanitizer and disinfectant designed for restaurant chains, food processors, and transportation companies, as well as PURE Control, a direct food contact processing aid. It also supplies SDC-based formulations as raw material ingredients for personal care products. Its SDC-based disinfecting and sanitizing products are registered with the United States Environmental Protection Agency, the United States Food and Drug Administration, and Health Canada.
Contact details
Important dates
General stock information
- Short code:
- PURE
- ISIN:
- US74621T2096
- Market cap:
- $7.16 million
- Shares in issue:
- 111.86 million
- Sector:
- Household Products
- Exchange:
- Off Exchange
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.